Methotrexate 50mg/2mL Injection$68.00
1–9 boxes
$68.00 each
10–24 boxes
8% off
25+ boxes
10% off
Methotrexate 50mg/2mL Injection
SKU GME915Product Introduction
Methotrexate 50mg/2mL Injection is an injectable folate-antagonist medicine used in selected rheumatoid arthritis, severe psoriasis and cancer regimens. Injectable treatment has indication-specific schedules and must not be confused with a routine daily injection.
How to use
A trained healthcare professional administers the injection using the route and schedule selected for the exact presentation and indication. Low-dose arthritis or psoriasis treatment is usually weekly, whereas oncology schedules differ. Concentration and total container dose are distinct measurements.
How it works
Methotrexate interferes with folate-dependent cellular pathways. Low-dose treatment reduces inflammatory immune activity, while oncology regimens inhibit proliferation of susceptible rapidly dividing cells.
Side effects
Nausea, mouth ulcers, fatigue, low blood counts, raised liver enzymes and injection-site discomfort can occur. Fever, unusual bruising, severe mucosal ulcers, dry cough or breathlessness needs urgent assessment.
Important information
Blood counts, kidney and liver function are monitored. Pregnancy is excluded because of fetal toxicity. Trimethoprim or co-trimoxazole can markedly increase marrow toxicity. Injectable products must not be assumed suitable for intrathecal use; preservative and presentation are critical.
Uses
- Selected rheumatoid arthritis or severe psoriasis regimens
- specified cancer treatment protocols.
Benefits
Provides parenteral methotrexate when the intended treatment requires an injectable route or oral treatment is not suitable.
Does the mg/mL value show the whole container dose?
No. It is a concentration. The total amount depends on the volume present; for example, 25mg/mL in 2mL contains 50mg.
Is Methotrexate 50mg/2mL a daily arthritis injection?
No. Low-dose methotrexate for inflammatory disease is generally weekly. Daily repetition can cause life-threatening toxicity.
Can every methotrexate injection be given by every route?
No. Route suitability depends on the exact preparation, concentration and preservatives; an injection label does not establish intrathecal suitability.
Is the injection equivalent to a pain-relief shot?
No. It is a disease-modifying or cytotoxic medicine, not an immediate analgesic.
Why might folate still be needed with injections?
Changing from tablets to injection does not remove all folate-related adverse effects; supplementation remains part of some low-dose regimens.
Can a fever wait until the next routine appointment?
Fever during methotrexate treatment can indicate infection or low white cells and needs prompt assessment.
Parenteral: administered by a route outside the digestive tract. Concentration: amount of medicine per unit volume. Cytotoxic: damaging or inhibiting rapidly dividing cells. Intrathecal: administration into the fluid space around the spinal cord; AR: Methotrexate 50mg/2mL حقن; FR: Methotrexate 50mg/2mL solution injectable; PT: Methotrexate 50mg/2mL solução injetável; ES: Methotrexate 50mg/2mL solución inyectable; RU: Methotrexate 50mg/2mL раствор для инъекций; ID: Methotrexate 50mg/2mL injeksi; VI: Methotrexate 50mg/2mL thuốc tiêm; MS: Methotrexate 50mg/2mL suntikan; TL: Methotrexate 50mg/2mL iniksyon; ZH-SG: Methotrexate 50mg/2mL 注射剂